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CONCLUSIONS
1. In contrast to S. aureus (reviewed in reference 2), sub-
inhibitory concentrations of nafcillin decreased toxin 
gene expression in GAS 88-003.  Thus, the effects of 
beta lactam antibiotics on toxin gene regulation 
appears to be species-, and perhaps, strain-specific. 
2. Sub-inhibitory concentrations of clindamycin 
significantly upregulated toxin gene transcription, 
though additional studies such as western blot 
analysis need to be performed to verify the absence of 
toxin production by clindamycin-treated GAS strain 
88-003.
3. The question remains as to whether the observed 
increase in toxin gene expression is due to direct 
effects on the toxin genes themselves, or whether it 
follows upregulation of toxin gene regulators.  Future 
studies to address this could utilize isogenic CsrR-
and/or Mga-deficient GAS strains. 
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ABSTRACT
Background: Streptococcus pyogenes, also known as group A 
streptococcus (GAS) or “the flesh-eating bacteria”, is a Gram positive 
human pathogen that causes many diseases, ranging in severity from 
milder infections such as pharyngitis to life-threatening necrotizing 
fasciitis/myonecrosis and streptococcal toxic shock syndrome (1).  
Although GAS remains susceptible to penicillin, this beta-lactam 
antibiotic (a cell wall-synthesis inhibitor) is not efficacious in treating 
severe GAS myonecrosis, whereas treatment with clindamycin (a 
lincosamide that inhibits protein synthesis) is 80-100% protective. We 
have previously demonstrated that sub-inhibitory concentrations of  the 
beta-lactam antibiotic, nafcillin, increases and prolongs extracellular 
protein production in Staphylococcus aureus, another Gram positive 
pathogen (2). The present study seeks to examine the effects of sub-
inhibitory concentrations of the antibiotics clindamycin, nafcillin, and 
penicillin on the expression of  toxin genes and toxin gene regulators in 
S. pyogenes. Methods: GAS strain 88-003 (M type 3) was isolated 
from a fatal case of necrotizing fasciitis and Strep TSS. The minimum 
inhibitory concentrations (MICs) of clindamycin, nafcillin, and penicillin 
were established through standard microbroth dilution assay. To 
determine the effects of antibiotics on gene expression, bacteria were 
cultured in the presence of sub-inhibitory concentrations of antibiotics 
(i.e., 0.5 x MIC) until the late-log phase of growth (4 h). Expression of 
toxin genes and global gene regulators were examined by northern 
analysis and reverse transcriptase (RT)-PCR.  Results: Clindamycin 
increased the expression of the genes coding for two exotoxins, namely 
streptolysin O (SLO,slo) and nicotine adenine dinucleotidase (NADase; 
nga).  It also increased expression of two global toxin gene regulators, 
csrR and mga. By contrast, 0.5 x MIC of nafcillin decreased the 
expression of these genes. The effects of penicillin at 0.5 x MIC were 
similar to that of nafcillin, except that penicillin caused a slight increase 
in csrR expression. Conclusions: Despite its well known ability to 
prevent translation of bacterial mRNA into exotoxins, clindamycin at 
sub-inhibitory doses augments toxin gene transcription in GAS.  The 
effects of beta lactam antibiotics on toxin gene regulation appears to be 
species-, and perhaps, strain-specific. 
INTRODUCTION
Despite decades of research, severe invasive GAS infections still 
occur with a frequency of 3.5/100,000 population per year and carry a 
mortality rate greater than 30%.  Survivors often undergo extensive 
surgical debridement, including amputation, and require prolonged 
hospitalization and rehabilitation.
Management of severe GAS infections requires immediate and 
intensive antibiotic treatment. The current consensus for treatment 
method is administration of high dose clindamycin, together with 
penicillin (3).  We have previously demonstrated in vitro that sub-
inhibitory concentrations of beta-lactam antibiotics augment the 
expression and production of toxin genes in Staphylococcus aureus, 
another Gram positive human pathogen, indicating that treatment of 
infections due to methicillin-resistant S. aureus may worsen outcomes 
(2).  Similarly, others have shown that clindamycin increased the levels 
of toxins SLO, NADase, and streptokinase in a clindamycin-resistant  
strain of Streptococcus pyogenes via its effects on the global regulator, 
CovR (aka CsrR) (4).  However, clindamycin resistance among GAS is 
rare and the effects of antibiotics on virulence factor gene expression in 
clindamycin-sensitive strains have not been reported.  
We utilized a clinical isolate of GAS associated with fatal 
necrotizing fasciitis and StrepTSS (GAS strain 88-003) to investigate 
the effects of subinhibitory antibiotics on toxin gene transcription by RT-
PCR and northern analysis.  Our results demonstrated that sub-
inhibitory concentrations of clindamycin, and to a lesser extent 
penicillin, greatly increased transcription of multiple toxin genes and 
known toxin gene regulators. Gaining insight into the effects of sub-
inhibitory concentrations of antibiotics on toxin gene expression could 
have profound implications on the choice and timing of antibiotics used 
for treatment of mild to severe GAS infections.
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Figure 1. Determination of 
minimum inhibitory concentrations 
(MICs) by microbroth dilution.  
Procedures employed followed NCCLS 
guidelines.  Briefly, 3 colonies of GAS 
were inoculated in10ml Todd Hewitt  
Broth (THB).  The culture was incubated 
at 37°C with 5% CO2 for 18 hours.  
Cultures were then diluted to an optical 
density (OD) at 625 nm of 0.08 - 0.1, 
which is equivalent  to ~1x108 cfu/ml. The 
cultures were then diluted 1:1000 to 
achieve a working concentration of 1x105
cfu/ml.  Antibiotics used (and their 
suppliers)  were:  clindamycin HCl 
(Pfizer); nafcillin sodium (Bristol-Myers 
Squibb), and sodium penicillin G 
(Sigma). Antibiotics were serially diluted  
2-fold in THB across the rows of a 96 
well plate (100 µl final volume). Then 100 
µl of the diluted bacterial culture was 
added.  The plate was incubated at 37°C 
with 5% CO2 overnight, and was then 
examined for bacterial growth.  The MIC 
was defined as the lowest concentration 
that effectively prevented visible bacterial 
growth. 
Figure 3. Validation of RT-PCR results by northern analysis. 3 µg of total RNA was 
hybridized with a 32P-labeled probe that was specific for either A) the gene coding for the 
exotoxin NADase (nga) or B) the global toxin gene response regulator, csrR. rRNA was used to 
show consistency in the amounts of total RNA loaded per lane.
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Figure 2. Gene expression analysis by real-time RT-PCR 0.5 µg RNA was isolated from late-log phase cultures 
(4 h) grown with 0.5 x MIC of specified antibiotics, and used as template for PCR (25µl).  cDNA synthesis and PCR 
was performed using SuperScript™III Platinum® One-Step Quantitative Kit (Invitrogen cat#11732-020) according to 
the manufacturer’s instructions. PCR settings were:  500C for 30 min, followed by 950C denaturation for 2 min, and 
then forty cycles of 15 seconds at 950C and 30 seconds at 550C. Fluorescence was detected at each 550C time 
point. Four oligonucleotide primer pairs and FAM-labeled probe sets (specific for nga, slo, csrR, or mga) were used 
to perform target amplification and detection. The transcript abundance is expressed relative to the abundance in the 
GAS 88-003 with no treatment (NT).
A. The MIC for clindamycin against GAS strain 88-003 was 0.03 µg/ml 
which is within the range reported for 90% of clindamycin-sensitive 
GAS (5). Experiments testing the effects of antibiotics on gene 
expression were conducted with 0.015 µg/ml clindamycin (i.e., 0.5 x 
MIC) and 10^8 cfu/ml of bacteria.
B. The MIC of nafcillin for GAS 88-003 was 0.03 µg/ml.  Experiments 
were conducted with 0.015 µg/ml nafcillin (0.5  x MIC). 
C. The MIC for penicillin against GAS 88-003 was 0.0037 µg/ml.  
Experiments were conducted with 0.0018 µg/ml penicillin (0.5 x MIC).  
The MIC90 of penicillin for GAS is 0.0075 – 0.06 µg/ml (5). 
A B
